Stock Market logoStock Market Station

All the stock market news, every minute updated!

19 September 2021
13:56 hour

Laurus Labs developing third-line HIV treatment for children

Money Works 4 Me

14/09/2021 - 14:59

The development is under way based on an agreement inked in June 2021 by the Hyderabad-based company, Unitaid and the Clinton Health Access Initiative


READ THE FULL ARTICLE ON MONEY WORKS 4 ME

Related headlines:

  1. Covid-19 3rd wave: Jagan Reddy govt in Andhra sets up pediatric hospitals for children (22/07/2021 - Financial Express)
    CM Jagan Mohan Reddy has already directed officials to formulate an action plan to save the children from the feared third Coronavirus wave. The official also said that the health infrastructure is being boosted up to cater to young children and treatment methods for children are also being prepared.
    [visit article]
  2. Covid-19 in children likely to induce MIS: What is this complication and its treatment explained (04/06/2021 - Financial Express)
    Children having Coronavirus infection have been witnessing a syndrome and this has become a cause of worry. Multisystem Inflammatory Syndrome (MIS), a Covid-19 linked syndrome is being detected in children and the union health ministry has directed all state governments to look out for this syndrome.
    [visit article]
  3. BlackSky (SFTW) vs Planet Labs (DMYQ) Advise? (07/09/2021 - Reddit Stocks)
    I have been looking at investing in the geospatial intelligence and space-based data and analytics that is being done by companies like BlackSky and Planet Labs. I think this technology and the different product lines these companies are developing has a lot of potential and a lot of potential customers. Looking for some advise on which company between BlackSky and Planet Labs has the best potential? Which company do you prefer and why compared to the other?   submitted by   /u/markmm [link]   [comments]
    [visit article]
  4. This Mother’s Day, here are 5 ways new moms can combat sleep troubles (09/05/2021 - Financial Express)
    A good night’s sleep is of paramount importance to children. Since children spend a significant amount of their time sleeping (and thereby growing and developing in their sleep) the decision of the right mattress becomes consequential.
    [visit article]
  5. Will Covid 3rd wave target children? Health Minister lists out opinion of top health experts (01/07/2021 - Financial Express)
    Quoting health experts, Dr Harsh Vardhan said that Coronavirus traced among children has been found to be mild in nature and rarely requires hospitalisation and adequate provisions have also been made for treatment of the same.
    [visit article]
  6. Is the cost of oximeter, oxygen cylinder covered in home care treatment of Corona Kavach policyholders? Find out (11/05/2021 - Financial Express)
    There has to be a continuous active line of treatment with monitoring of the health status by a medical practitioner for each day through the duration of the home care treatment.
    [visit article]
  7. Roche announces launch of Evrysdi® (risdiplam) for treatment of  SMA patients in India (29/07/2021 - Financial Express)
    Evrysdi® (risdiplam) is the first and only oral treatment for adults and children two months or older suffering from SMA, now available in India
    [visit article]
  8. ProPhase Labs EPS in-line, beats on revenue (13/05/2021 - Seeking Alpha)

    [visit article]
  9. ED files money laundering case in fake Covid testing during Kumbh; conducts raids (06/08/2021 - Financial Express)
    Searches were conducted at the offices of Novus Path Labs, DNA Labs, Max Corporate Services, Dr Lal Chandani Labs Pvt Ltd and Nalwa Laboratories Pvt Ltd and also at the residential premises of their directors in Dehradun, Haridwar, Delhi, Noida and Hisar, the agency said in a statement.
    [visit article]
  10. Centre should procure as many vaccines as possible to keep children safe: Manish Sisodia (09/06/2021 - Financial Express)
    The ruling AAP dispensation led by Chief Minister Arvind Kejriwal has voiced concern over safety of children while citing opinion of experts that children may be affected in a possible third wave of COVID-19.
    [visit article]
  11. Covid-19: 17 more labs to now monitor variants (18/05/2021 - Financial Express)
    Vardhan, while announcing this at the 26th meeting of the group of ministers (GoM), informed that the 17 labs were going to be added to the INSACOG network to increase the number of samples screened. The INSACOG network is currently served by 10 labs across India that are tracking emerging variants and mutants in the second wave.
    [visit article]
  12. Covid-19 among children: Fear of third wave, precautions and other concerns explained (07/06/2021 - Financial Express)
    Coronavirus has surely made it difficult for management of everyday routine with infants and children. The anxiety among people is now increasing as more cases of infection of Covid-19 in children have surfaced.
    [visit article]
  13. CURE Pharma's Sera labs unveils ImmunD3 offering to its nutri-strips product line (10/02/2021 - Seeking Alpha)

    [visit article]
  14. 3rd wave: K’taka begins genome study of Covid-19 hit children (17/06/2021 - Financial Express)
    As part of the study, scientists are trying to understand whether Covid-19 among children spread from the existing variants of the virus or used a new variant to enter the body of children.
    [visit article]
  15. Inoculating children against Covid-19 infection to begin; check all countries in favour of vaccinating children (03/06/2021 - Financial Express)
    As the time passes by, it has become crucial to safeguard children from the Covid-19 infection as the emerging new strains are impacting them severely.
    [visit article]
  16. What’s latest on Covid vaccines? Here’s what you need to know from labs of Pfizer, J&J, Moderna, Oxford-AstraZeneca (26/02/2021 - Financial Express)
    Covid Vaccine Update: Developing a vaccine against the Coronavirus seems to be not enough as researchers are continuously trying to improve the quality and the products are under relentless scrutiny.
    [visit article]
  17. Digital Language labs help students in increasing command & proficiency over languages; Here’s how (15/06/2021 - Financial Express)
    Communication & connect have become of supreme importance today in creating a successful career. Thus education Institutes & Colleges have started focussing on developing languages as skill among the learners.
    [visit article]
  18. Buying health insurance? Here are the most common exclusions you should know (13/07/2021 - Financial Express)
    Health Insurance Exclusions: a health insurance claim would be admitted only if all the 3 conditions are fulfilled, such as doctor’s advice of hospitalisation, standard protocol for treatment and an active line of treatment has been administered.
    [visit article]
  19. Dr Reddy’s developing new treatment options for COVID-19, says MD (23/05/2021 - Financial Express)
    The Hyderabad-based drug major has already launched Sputnik V vaccine while partnering various organisations, including the Defence Research and Development Organisation.
    [visit article]
  20. Stock market and its returns (13/07/2021 - Reddit Stock Market)
    Hello .I am from India. my portfolio consists of 31 stocks out of which 60 % are large cap and 40% are mid cap. If I invest 2 lakhs into each of my stocks , then can I get a return of 6 crores in 10 years .if most of my stocks give a cagr of 20-26% , then I can get 10x returns ? Pidilite - 3x , Hindustan Unilever - 2.69x, Tata consultancy services ( TCS ) - 2.50x, Asian paints - 2.95x, Shri jagdamba polymers limited - 19.48x HDFC Bank limited - 2.55x Titan - 4.74x, Infosys - 2.39x, Bajaj finance - 7.20x Reliance industries limited - 4.54x, Astral poly technik - 7.38x Relaxo footwears limited - 4.69x Kotak Mahindra Bank - 2.39x Bajaj finserv - 6.42x Tata elxsi - 4x L and t technology services - 3.36x Deepak nitrite - 22x Divis laboratories- 4x Dmart - 5.46x Alkyl amines - 26x Jubliant foodworks - 6.22x Laurus labs - 6x Aarti industries- 7x Dixon technologies- 8.6x Naukri ( infoedge ) - 5.85x Polycab - 3.11x Coforge - 2.10x Abbot - 3.69x Affle India - 5.18x Happiest minds - 3.34x Mindtree -3.91x X is the number of times of returns the stock has given in the past 5 years .   submitted by   /u/LeopardLast6367 [link]   [comments]
    [visit article]
  21. JNJ highlights potential of IMBRUVICA as a first-line treatment for leukemia (20/05/2021 - Seeking Alpha)

    [visit article]
  22. FDA OKs expanded use of Pfizer’s Lorbrena as first-line treatment in lung cancer (04/03/2021 - Seeking Alpha)

    [visit article]
  23. Merck's Keytruda approved as first-line gastric cancer treatment (05/05/2021 - Seeking Alpha)

    [visit article]
  24. FDA approves Bristol's Opdivo as first-line gastric cancer treatment (16/04/2021 - Seeking Alpha)

    [visit article]
  25. Parents take note! If there is only one Gift you can give children, let it be this! (15/03/2021 - Financial Express)
    Seeing one’s own children struggle can be one of the most painful experiences for a parent.
    [visit article]
  26. Dealing With Anxiety during the MBA Journey of Your Children (20/07/2021 - Financial Express)
    If you use these insights, you will not only become a catalyst for your children’s career growth, but for your own mental health and well-being as well.
    [visit article]
  27. Merck’s Keytruda combo OK'd in China for first-line treatment of esophageal cancer (07/09/2021 - Seeking Alpha)

    [visit article]
  28. Lilly's Tyvyt 'significantly improves' overall survival as a second-line treatment for lung cancer (13/04/2021 - Seeking Alpha)

    [visit article]
  29. Genentech's Polivy meets primary endpoint as first-line treatment for B-cell lymphoma (09/08/2021 - Seeking Alpha)

    [visit article]
  30. Coronavirus outbreak: Need research on Covid-19 shots for children (05/04/2021 - Financial Express)
    Millions of children from low-income families will be worse off in their later years if schooling remain disrupted
    [visit article]
  31. ‘Meal of Joy’ for homeless children! The Burger Company India rolls out initiative during Covid-19 second wave (20/05/2021 - Financial Express)
    Notably, The Burger Company India has taken a notable initiative to feed homeless children free of cost and to reach out to as many children living on the streets as possible.
    [visit article]
  32. Merck KGaA reports bintrafusp alfa data as second-line treatment in gastrointestinal cancer (16/03/2021 - Seeking Alpha)

    [visit article]
  33. Pine Labs raises $285 million in fresh funding (17/05/2021 - Financial Express)
    “In this significantly oversubscribed round, in addition to primary proceeds, Pine Labs enabled secondary transactions for its founder, employees and early shareholders,” the company said in a statement.
    [visit article]
  34. 2021 for sustainability: Why parents should inculcate children to use eco-friendly products (04/03/2021 - Financial Express)
    “We do not inherit the Earth from our ancestors, we borrow it from our children,” said the illustrious Ralph Waldo Emerson.
    [visit article]
  35. 2 STOCKS TO WATCH / BUY / BIG GAINS (21/07/2021 - Reddit Stock Market)
    OSMT - The only propriety product to treat droopy eyes. Will be the next Botox but only requires a drip in your eye once a day, otherwise you would need surgery. They sold off their legacy business and are raising capital to push Upneeq (their product) and are gaining strength really quickly. Get in cheap and watch it double, triple, quadruple. SIGA - ST246 - only available treatment for smallpox outbreak in the US or any formulary. Smallpox far more deadly than covid - 20x more deadly - horrific disease - eradicated but remains in a number of government arsenals - a relative of smallpox is called monkeypox - and there is now a developing outbreak of monkeypox in the US, 200 possible causes in the US and ST246 is also the ONLY treatment.   submitted by   /u/ManiacXaq [link]   [comments]
    [visit article]
  36. Opdivo/Yervoy combo shows long-term survival benefit as first-line mesothelioma treatment (13/09/2021 - Seeking Alpha)

    [visit article]
  37. The Children’s Place, Inc. (PLCE) Q4 2020 Earnings Call Transcript (09/03/2021 - AlphaStreet)
    The Children’s Place, Inc. (NASDAQ: PLCE) Q4 2020 earnings call dated Mar. 09, 2021 Presentation: Operator Good morning, and welcome to The Children’s Place Fourth Quarter and Full-Year 2020 Earnings… This content is for members only. Visit the site and log in/register to read.The post The Children’s Place, Inc. (PLCE) Q4 2020 Earnings Call Transcript first appeared on AlphaStreet.
    [visit article]
  38. The Moneyist: My fiancé wants me off the deed and mortgage to our new home. If I don’t agree, he says we’ll stay engaged forever (08/02/2021 - Market Watch)
    ‘The house is appreciating daily due to its location, and he wants his children to inherit it. He wants me to pay rent, which essentially leaves nothing for my children.’
    [visit article]
  39. How do I find out the list of venture capitalist fund investors submitted to the SEC? (09/08/2021 - Reddit Stocks)
    I am trying to find out who are the 225 VCs that funded Intangible Labs, creator of the now defunct Basis.io project. I have been able to find about 35 of the VCs, but not any more than that. Is there some way I can obtain the full list from the SEC or another organization? Intagible Labs Form D filing: https://www.sec.gov/Archives/edgar/data/1734381/000173438118000001/xslFormDX01/primary_doc.xml Coindesk article: According to a Form D document submitted to the U.S. Securities and Exchange Commission (SEC), Intangible Labs raised the funds via SAFT from 225 investors between March 22 and April 3.   submitted by   /u/EpicMichaelFreeman [link]   [comments]
    [visit article]
  40. Supreme Court seeks response from Morepen Labs in 2003 case (02/08/2021 - Financial Express)
    Counsel Somasekhar Sundaresan, appearing for Morepen Labs, however, opposed Sebi appeal, saying that the GDR issue took place in 2003 and the show cause notice was issued in 2017, after so much delay.
    [visit article]
  41. The Moneyist: My second husband, 86, and I have 12 kids between us. He wants me to leave him everything — and says he will pass on the inheritance to my 5 children (06/04/2021 - Market Watch)
    ‘He wants to leave the house to his children, but says if I outlive him I can live in it or rent somewhere if I wish to move.’
    [visit article]
  42. Guide for parents to keep their children safe during the Covid-19 pandemic (04/06/2021 - Financial Express)
    By following simple steps and being aware of all medical precautions advised by paediatricians, parents can keep their children fit during these unprecedented times.
    [visit article]
  43. Why rare diseases in India require robust government support to save patients’ lives (25/08/2021 - Financial Express)
    An approach backed by urgency and compassion can save precious lives of children and other patients of rare diseases, who can ill afford extremely expensive treatment costs.
    [visit article]
  44. Pharming biopharmaceutical company (27/08/2021 - Reddit Stocks)
    Pharming is a global, commercial stage biopharmaceutical company developing innovative protein replacement therapies and precision medicines for the treatment of rare diseases and unmet medical needs. The flagship of our portfolio is our recombinant human C1 esterase inhibitor, or rhC1INH, franchise. C1INH is a naturally occurring protein that downregulates the complement cascade in order to control swelling in affected tissues. Our lead product, RUCONEST® is the first and only plasma-free rhC1INH protein replacement therapy. It is approved for the treatment of acute hereditary angioedema, or HAE, attacks. We are commercializing RUCONEST® in the United States, the European Union and the United Kingdom through our own sales and marketing organization, and the rest of the world through our distribution network. We are also developing rhC1INH for subsequent indications, including pre- eclampsia, Acute Kidney Injury and we are also investigating the clinical efficacy of rhC1INH in COVID-19. In addition, we are studying our oral precision medicine, leniolisib (a phosphoinositide 3-kinase delta, or PI3K delta, inhibitor), for the treatment of activated PI3K delta syndrome, or APDS, in a registration enabling Phase 2/3 study in the US and Europe. Furthermore, we are also leveraging our transgenic manufacturing technology to develop next-generation protein replacement therapies most notably for Pompe disease, which program is currently in the preclinical stage. Pharming’s lead product, RUCONEST® (conestat alfa) is a recombinant human C1 esterase inhibitor approved for the treatment of acute hereditary angioedema (“HAE”) attacks in patients in Europe, the US, Israel and South Korea. The product is available on a named-patient basis in other territories where it has not yet obtained marketing authorization.   submitted by   /u/Go_StreetBB [link]   [comments]
    [visit article]
  45. ProventionBio is a steal right now (28/06/2021 - Reddit Stocks)
    I wanted to give everybody a heads-up with one stock, ProventionBio, as I expect this to go up significantly this year due to the release of a new drug in July. ProventionBio (PRVB) is a pharmaceutical company whose target approach is to prevent the onset or progression of disease. They currently have no marketed drug, but have one drug in the pipeline to prevent disease progression of Type I Diabetes. This drug, teplizumab, is expected to be approved on July 2nd. It has already been incorporated into the American Diabetes Association guidelines to be given at early onset to prevent/delay progression into full-blown Type 1 diabetes. Here’s why I think PRVB will be worth significantly more after the release of teplizumab. Type I Diabetes occurred in 1.4 million adults and 187,000 children in 2020 alone. If half of these people were given teplizumab which experts believe to be very high (50-100 thousand per treatment course), this will make the company lots of money. The company currently has a market cap of 580M. If the cost of treatment is $50,000 and only 250,000 patients received the dose, that is 12.5 billion per year. Studies are also showing that many more diabetic cases in adults are caused by Type 1, and not type 2 diabetes, meaning that the market for this drug is only going up. The stock is a steal right now, as there was a setback for PRVB a couple months ago. All data from the clinical trial shows teplizumab to work well at delaying T1D onset. However, absorption studies were not consistent due to using old technology from when PRVB bought teplizumab from Eli-Lily. The FDA said that their absorption and other pharmacokinetic data needs to be more consistent before it would be approved. The company needs to just use more modern approach to developing the drug to get consistent absorption of the drug, which is very doable as monoclonal antibody based drugs are extremely common these days. Once that is fixed, it should be approved as an FDA advisory committee already recommended approval in late May. This drug did receive a fast-track designation due to its potential impact on Type 1 Diabetes. ProventionBio also has other drugs in the pipeline for Celiac Disease (currently no treatment) and lupus. I have great faith in this stock going way up in the next few years! I am not a financial advisor, but am a pharmacist, and just like the stock!   submitted by   /u/BlibbityBlew [link]   [comments]
    [visit article]
  46. : The ‘hidden pandemic of orphanhood’: An estimated 1.5 million children have lost a caregiver to COVID-19 (21/07/2021 - Market Watch)
    'Overall, there were up to five times more children who lost a father than who lost a mother.'
    [visit article]
  47. Cancer in children: The unseen impact of cancer on education (02/08/2021 - Financial Express)
    As per a Lancet study, India alone witnesses more than 50,000 cases of cancer in children under 19 years of age every year.
    [visit article]
  48. Eye on the future: Giving our children a ‘bright’ future (16/02/2021 - Financial Express)
    States must partner the private sector, including healthcare providers, health-tech start-ups, to provide solutions for early detection of vision defects in children
    [visit article]
  49. Apollo Hospitals ties up with Anatomiz3D Medtech to set up hospital 3D printing labs (17/02/2021 - Financial Express)
    The hospital 3D printing labs would provide medical 3D printing services for better healthcare, through the creation of anatomical models for pre-surgical planning and education, patient-specific cutting and drilling guides, and customised implants and implant moulds.
    [visit article]

For more information mailto [email protected]. Disclaimer.